141 related articles for article (PubMed ID: 26483344)
1. Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.
Tsui H; Zi M; Wang S; Chowdhury SK; Prehar S; Liang Q; Cartwright EJ; Lei M; Liu W; Wang X
Hypertension; 2015 Dec; 66(6):1176-83. PubMed ID: 26483344
[TBL] [Abstract][Full Text] [Related]
2. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
Liu W; Zi M; Naumann R; Ulm S; Jin J; Taglieri DM; Prehar S; Gui J; Tsui H; Xiao RP; Neyses L; Solaro RJ; Ke Y; Cartwright EJ; Lei M; Wang X
Circulation; 2011 Dec; 124(24):2702-15. PubMed ID: 22082674
[TBL] [Abstract][Full Text] [Related]
3. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
Li HH; Willis MS; Lockyer P; Miller N; McDonough H; Glass DJ; Patterson C
J Clin Invest; 2007 Nov; 117(11):3211-23. PubMed ID: 17965779
[TBL] [Abstract][Full Text] [Related]
4. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
[TBL] [Abstract][Full Text] [Related]
5. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
Skurk C; Izumiya Y; Maatz H; Razeghi P; Shiojima I; Sandri M; Sato K; Zeng L; Schiekofer S; Pimentel D; Lecker S; Taegtmeyer H; Goldberg AL; Walsh K
J Biol Chem; 2005 May; 280(21):20814-23. PubMed ID: 15781459
[TBL] [Abstract][Full Text] [Related]
6. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
7. Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.
Usui S; Maejima Y; Pain J; Hong C; Cho J; Park JY; Zablocki D; Tian B; Glass DJ; Sadoshima J
Circ Res; 2011 Jul; 109(2):161-71. PubMed ID: 21617130
[TBL] [Abstract][Full Text] [Related]
8. Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells.
Li JJ; Zhang TP; Meng Y; Du J; Li HH
Cell Physiol Biochem; 2011; 27(5):463-70. PubMed ID: 21691063
[TBL] [Abstract][Full Text] [Related]
9. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
10. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
Li HH; Kedar V; Zhang C; McDonough H; Arya R; Wang DZ; Patterson C
J Clin Invest; 2004 Oct; 114(8):1058-71. PubMed ID: 15489953
[TBL] [Abstract][Full Text] [Related]
11. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
[TBL] [Abstract][Full Text] [Related]
12. MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.
Baskin KK; Rodriguez MR; Kansara S; Chen W; Carranza S; Frazier OH; Glass DJ; Taegtmeyer H
J Mol Cell Cardiol; 2014 Jul; 72():168-76. PubMed ID: 24650875
[TBL] [Abstract][Full Text] [Related]
13. Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System.
Murdoch JD; Rostosky CM; Gowrisankaran S; Arora AS; Soukup SF; Vidal R; Capece V; Freytag S; Fischer A; Verstreken P; Bonn S; Raimundo N; Milosevic I
Cell Rep; 2016 Oct; 17(4):1071-1086. PubMed ID: 27720640
[TBL] [Abstract][Full Text] [Related]
14. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.
Mei Z; Zhang D; Hu B; Wang J; Shen X; Xiao W
J Biol Chem; 2015 Jun; 290(26):16202-14. PubMed ID: 25944903
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional effects of E3 ligase atrogin-1/MAFbx on apoptosis, hypertrophy and inflammation in neonatal rat cardiomyocytes.
Zeng Y; Li J; Wang HX; Guo SB; Yang H; Zeng XJ; Fang Q; Tang CS; Du J; Li HH
PLoS One; 2013; 8(1):e53831. PubMed ID: 23335977
[TBL] [Abstract][Full Text] [Related]
16. Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
Yan L; Huang H; Tang QZ; Zhu LH; Wang L; Liu C; Bian ZY; Li H
J Cell Biochem; 2010 Apr; 109(6):1158-71. PubMed ID: 20127712
[TBL] [Abstract][Full Text] [Related]
17. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.
Mao K; Kobayashi S; Jaffer ZM; Huang Y; Volden P; Chernoff J; Liang Q
J Mol Cell Cardiol; 2008 Feb; 44(2):429-34. PubMed ID: 18054038
[TBL] [Abstract][Full Text] [Related]
19. Ventricular SK2 upregulation following angiotensin II challenge: Modulation by p21-activated kinase-1.
Yang B; Jiang Q; He S; Li T; Ou X; Chen T; Fan X; Jiang F; Zeng X; Huang CL; Lei M; Tan X
J Mol Cell Cardiol; 2022 Mar; 164():110-125. PubMed ID: 34774547
[TBL] [Abstract][Full Text] [Related]
20. FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development.
Sahu SK; Tiwari N; Pataskar A; Zhuang Y; Borisova M; Diken M; Strand S; Beli P; Tiwari VK
Nat Commun; 2017 Nov; 8(1):1523. PubMed ID: 29142217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
